Pantoprazole Sodium
Product Images NDC 70934-441

4 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 70934-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1843d24f 2e80 4749 Becc 9def6c3607c7 01)

Image (1843d24f 2e80 4749 Becc 9def6c3607c7 01)
Chemical structure of Pantoprazole Sodium, showing the molecular structure including aromatic rings, sulfur, nitrogen atoms, and fluorine substituents, along with water of hydration (1.5 H2O) and sodium ion (Na+).*
FDA Label Image

1 (1843d24f 2e80 4749 Becc 9def6c3607c7 02)

FDA Label Image

Torrent Logo (1843d24f 2e80 4749 Becc 9def6c3607c7 03)

FDA Label Image

Label (70934 441 30 Rev A 09 19)

Label (70934 441 30   Rev A 09 19)
Pantoprazole Sodium Delayed-Release Tablets USP 20mg 30 Tablets carton label. The label includes dosage information, storage instructions, and warnings. Manufactured and packaged by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label displays the product NDC 70934-441-30 with directions for Rx use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.